Eli Lilly's performance in the biopharmaceutical sector reflects its strong market position, despite facing challenges. The ...

In 2023, SlimFast lost 33pc of its sales in three months as the jabs exploded in popularity. Sold under brands like Wegovy ...

Viking Therapeutics (NASDAQ: VKTX) soared into the spotlight about a year ago when it delivered promising data on a drug ...

A COLCHESTER pharmacy boss is “delighted” to offer a weight loss drug which has been used by celebrities through a new ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Tennessee Attorney General Jonathan Skrmetti led a 38-state bipartisan coalition last week requesting that the Food and Drug ...

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...

Legislators may launch a study of how weight loss drugs might reduce costs in the Iowa Medicaid program. Jeffrey Boeyink is a ...

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

If Australia followed England’s lead and listed drugs such as Wegovy on the PBS for weight loss, this could bring the cost ...

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new ...

Studies have shown GLP-1 medications have other health benefits, including lowering the risk of certain diseases and addictions, like drinking and smoking.